| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alzamend Neuro, Inc. (ALZN) has 3 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. ALZN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 25 | $26.00 | - | |
| Dir | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 12, 2022 | Ault Milton C III | 10% Owner | Buy | 2,000 | $1.23 | $2,466.80 | - | -54.5% | -82.1% | |
| Oct 6, 2022 | Ault Milton C III | 10% Owner | Buy | 1,000 | $1.43 | $1,429.30 | - | -58.9% | -83.9% | |
| Sep 29, 2022 | Ault Milton C III | 10% Owner | Buy | 3,500 | $1.19 | $4,152.75 | - | -55.5% | -80.1% | |
| Sep 19, 2022 | Jackman Stephan | Chief Executive Officer | Buy | 8,500 | $1.23 | $10,414.20 | New | -37.4% | -82.0% | |
| Sep 14, 2022 | Katzoff David J | Chief Financial Officer | Buy | 10,000 | $1.11 | $11,092.00 | +55.6% | -7.0% | -80.3% | |
| Aug 26, 2022 | Ault Milton C III | 10% Owner | Buy | 9,100 | $0.94 | $8,561.28 | - | +31.9% | -71.1% | |
| Aug 25, 2022 | Ault Milton C III | 10% Owner | Buy | 4,900 | $0.96 | $4,703.51 | - | +26.6% | -71.3% | |
| Aug 22, 2022 | Ault Milton C III | 10% Owner | Buy | 36,000 | $0.97 | $34,894.80 | +0.4% | +16.5% | -70.1% | |
| Aug 16, 2022 | Ault Milton C III | 10% Owner | Buy | 15,000 | $1.08 | $16,213.50 | +0.2% | -1.8% | -73.4% | |
| Aug 15, 2022 | Ault Milton C III | 10% Owner | Buy | 14,000 | $1.06 | $14,833.00 | +0.1% | +2.9% | -70.3% |